Aligos Therapeutics, Inc. (ALGS)
Biological Products, (No Diagnostic Substances)
Latest Price
$4.23
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.06
P/B Ratio
1.38
Institutional Ownership
44.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 444.1K | $3.0M | 7.18% | -- | 2026-03-31 |
| Alyeska Investment Group, L.P. | 412.0K | $3.0M | 6.66% | -- | 2026-03-31 |
| Sio Capital Management, LLC | 327.2K | $2.0M | 5.29% | -8.7K | 2026-03-31 |
| MARSHALL WACE, LLP | 267.1K | $1.0M | 4.32% | -1.5K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 229.8K | $1.0M | 3.71% | +216.6K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 178.3K | $1.0M | 2.88% | -- | 2026-03-31 |
| Woodline Partners LP | 177.4K | $1.0M | 2.87% | -111.8K | 2026-03-31 |
| SummitTX Capital, L.P. | 148.8K | $1.0M | 2.40% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 100.5K | -- | 1.62% | +15.0K | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 83.1K | -- | 1.34% | -- | 2026-03-31 |